Hualan Biological Engineering,Inc.

In the process of endogenous blood coagulation, as a cofactor, in the presence of Ca2 and phospholipids, it participates in the activation of prothrombin by coagulation factor X with activated coagulation factor IX to form thrombin, thereby allowing the coagulation process to proceed normally. Infusion of 1 unit of human coagulation factor VIII per kilogram of body weight can increase the level of factor VIII in the circulating blood by 2% to 2.5%.

During the coagulation process, fibrinogen is hydrolyzed by thrombin into fibrin. Under the action of fibrin-stabilizing factor (FXIII), solid fibrin is formed, which plays an effective hemostatic role.

Immunoglobulin injection is a passive immunotherapy that transfers a large amount of antibodies contained in immunoglobulin to the recipient, allowing the recipient to quickly reach a temporary immune protection state from a low or no immune state. The interaction between antibodies and antigens directly neutralizes toxins and kills bacteria and viruses, and has a certain effect on preventing bacterial and viral infections.

This product contains broad-spectrum IgG antibodies against viruses, bacteria or other pathogens, and has dual therapeutic effects of immune replacement and immune regulation. After intravenous infusion, it can rapidly increase the IgG level in the recipient's blood, enhancing the body's anti-infection ability and immune regulation function.

The specific pharmacological effect is not clear from the above information